TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14583310

Group type: EXPERIMENTAL
Intervention: RHA-OPCAB
Number of subjects: 100

Group type: COMPARATOR
Intervention: cCABG
Number of subjects: 100
Study: 10787430

Group type: EXPERIMENTAL
Intervention: margarine with phytosterol esters (MSE) (1.84 g/d)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: margarine with phytostanol esters (MSA) (1.84 g/d)
Number of subjects: 15

Group type: COMPARATOR
Intervention: margarine (M)
Number of subjects: 15
Study: 8887803

Group type: EXPERIMENTAL
Intervention: Dentifrice containing salivary peroxidase elements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline values
Number of subjects: 0
Study: 1699400

Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium antagonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Class I antiarrhythmic agents (flecainide and encainide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Class III antiarrhythmic agents (amiodarone)
Number of subjects: 0
Study: 342629

Group type: EXPERIMENTAL
Intervention: Whole-virus vaccine (50 CCA units)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Whole-virus vaccine (two inoculations)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Split-product vaccine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31856081

Group type: EXPERIMENTAL
Intervention: nal-IRI + 5-FU/LV
Number of subjects: 417

Group type: COMPARATOR
Intervention: 5-FU/LV
Number of subjects: 417
Study: 30952216

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control therapy (CTRL)
Number of subjects: 139
Study: 28198465

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Norepinephrine-dopamine reuptake inhibitor (bupropion)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 25957981

Group type: EXPERIMENTAL
Intervention: LP-PRP
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study: 23124786

Group type: EXPERIMENTAL
Intervention: Oxymetholone
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 21802026

Group type: EXPERIMENTAL
Intervention: ICX72 (Capsaicin nasal spray)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 18708287

Group type: EXPERIMENTAL
Intervention: 6 g/day arginine (ARG trial)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (CON trial)
Number of subjects: 10
Study: 22892773

Group type: EXPERIMENTAL
Intervention: 0.1 ml saline solution of Propionium bacterium parvum, one dose a month for 3 to 5 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.1 ml intradermal injection of placebo solution
Number of subjects: 20
Study: 15913168

Group type: EXPERIMENTAL
Intervention: External suction drainage (ESD) system
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional internal suction drainage (ISD) system
Number of subjects: 42
Study: 12902415

Group type: EXPERIMENTAL
Intervention: (99m)Tc‐Sestamibi scintigraphy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: (99m)Tc‐Sestamibi scintigraphy in ERT-naive patients
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: (99m)Tc‐Sestamibi scintigraphy in ERT-treated patients
Number of subjects: 72
Study: 9579503

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Holter electrocardiography (ECG)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Both TEE and ECG
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: TEE
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: ECG
Number of subjects: 351
Study: 8617535

Group type: EXPERIMENTAL
Intervention: Education and awareness of immunization among health personnel
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Attaching immunization slip to the outpatient form
Number of subjects: 634

Group type: COMPARATOR
Intervention: Baseline survey (Phase-I)
Number of subjects: 634

Group type: COMPARATOR
Intervention: Phase-II and Phase-III surveys after interventions
Number of subjects: 634
Study: 2644803

Group type: EXPERIMENTAL
Intervention: Amylose starch
Number of subjects: 12

Group type: COMPARATOR
Intervention: Amylopectin starch
Number of subjects: 12
Study: 556821

Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30431535

Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (INT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 28
Study: 28804801

Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme supplementation diet (PES‐d)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normal diet (Normal‐d)
Number of subjects: 43
Study: 27117753

Group type: EXPERIMENTAL
Intervention: Desmopressin (0.3 μg/kg in saline solution)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 135
Study: 26586385

Group type: EXPERIMENTAL
Intervention: Probiotic E. coli Nissle 1917 for 6 weeks
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 23636302

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg, n=42)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Nicotine gum (4 mg, n=24)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo gum (n=66)
Number of subjects: 132
Study: 20113522

Group type: EXPERIMENTAL
Intervention: Participatory intervention with parents as the primary target group, engaging them in developing and implementing project ideas to promote physical activity.
Number of subjects: 37

Group type: COMPARATOR
Intervention: State-sponsored programme providing structured gym lessons to preschool children (control group).
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Participatory intervention with parents as the primary target group.
Number of subjects: 37
Study: 18096304

Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of Sonazoid (0.6 microL microbubbles/kg body weight)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Continuous infusion of Sonazoid (1.2 microL microbubbles/kg body weight over 30 min)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both bolus injection and continuous infusion of Sonazoid
Number of subjects: 32
Study: 15899104

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 147

Group type: COMPARATOR
Intervention: Divalproex
Number of subjects: 147
Study: 12816354

Group type: EXPERIMENTAL
Intervention: Group E: 1.5 mL/kg, 370 mgI/mL, 5 mL/sec
Number of subjects: 125

Group type: COMPARATOR
Intervention: Group A: 100 ml, 300 mgI/mL, 3 mL/sec
Number of subjects: 125

Group type: COMPARATOR
Intervention: Group B: 2 mL/kg, 300 mgI/mL, 3 mL/sec
Number of subjects: 125

Group type: COMPARATOR
Intervention: Group C: 1.5 mL/kg, 370 mgI/mL, 3 mL/sec
Number of subjects: 125

Group type: COMPARATOR
Intervention: Group D: 2 mL/kg, 300 mgI/mL, 5 mL/sec
Number of subjects: 125
Study: 10498008

Group type: EXPERIMENTAL
Intervention: Sustained convergence for 30 seconds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained convergence for 60 seconds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained convergence for 90 seconds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control duration of 5 seconds
Number of subjects: 0
Study: 7847251

Group type: EXPERIMENTAL
Intervention: Superselective carboplatin (200 mg/m2 and 300 mg/m2) with concurrent infusional 5-fluorouracil (225 mg/m2) and radiotherapy
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Continuous infusional 5-fluorouracil
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Superselective carboplatin delivery
Number of subjects: 19
Study: 1719112

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soft tissue manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Substance P (SP) preincubation (1 x 10(‐11) M, 5 x 10(‐11) M, 1 x 10(‐10) M)
Number of subjects: 0
Study: 7333744

Group type: EXPERIMENTAL
Intervention: Submaximum exercise at 88 W
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Submaximum exercise at 118 W
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Blood donation reducing Hb by 18.6%
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Submaximum exercise Q 6 days post-blood donation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Submaximum exercise Q 11 days post-blood donation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Submaximum exercise Q 16 days post-blood donation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Submaximum exercise Q 21 days post-blood donation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Comparison of stroke volume (SV) post-blood donation
Number of subjects: 28
Study: 30968444

Group type: EXPERIMENTAL
Intervention: 500 U C1‐INH, twice weekly for 12 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1000 U C1‐INH, twice weekly for 12 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both doses of C1‐INH
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 500 U C1‐INH
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1000 U C1‐INH
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: C1‐INH prophylaxis
Number of subjects: 12
Study: 27460979

Group type: EXPERIMENTAL
Intervention: 25% glucose (G25)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Non-nutritive sucking (NNS)
Number of subjects: 78
Study: 24698195

Group type: COMPARATOR
Intervention: Percutaneous nephrostomy (PCN) tube
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: JJ ureteric stenting
Number of subjects: 90
Study: 23911345

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass surgery
Number of subjects: 43

Group type: COMPARATOR
Intervention: Intensive lifestyle intervention (diet and exercise)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: None of the above
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Unsure
Number of subjects: 43
Study: 21653717

Group type: EXPERIMENTAL
Intervention: Stereoscopic gradients applied to expanding dot patterns during fMRI scanning, with consistent depth cues (peripheral dots near, central dots far)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Stereoscopic gradients applied to expanding dot patterns during fMRI scanning, with inconsistent depth cues (central dots near, peripheral dots far)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Stereoscopic gradients applied to expanding dot patterns during fMRI scanning, with zero-disparity gradients
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Stereoscopic gradients applied to expanding dot patterns during fMRI scanning
Number of subjects: 13
Study: 19058059

Group type: EXPERIMENTAL
Intervention: Nasal administration of 17beta-estradiol
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 17721962

Group type: EXPERIMENTAL
Intervention: Overshadowing the Threat of Terrorism program (8 sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 15213488

Group type: EXPERIMENTAL
Intervention: Individualized feedback group (n = 195)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Minimal intervention group (n = 87)
Number of subjects: 282
Study: 11107086

Group type: EXPERIMENTAL
Intervention: Duplex ultrasound scanning
Number of subjects: 100

Group type: COMPARATOR
Intervention: Computed tomographic (CT) angiography
Number of subjects: 100
Study: 9490625

Group type: EXPERIMENTAL
Intervention: Antibodies against IgE and IgD; tested using ELISA with peroxidase conjugated antibodies.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific IgG, IgM, and IgA antibodies with polysaccharide from Neisseria meningitidis serotype A; studied during vaccine testing.
Number of subjects: 0
Study: 8195853

Group type: EXPERIMENTAL
Intervention: Brodimoprim (10 mg/kg on the first day, 5 mg/kg/day thereafter)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Brodimoprim
Number of subjects: 170

Group type: COMPARATOR
Intervention: Erythromycin (560 mg/kg/8 hours)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid (50 mg/kg/12 hours)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control groups (Erythromycin and Amoxicillin/clavulanic acid)
Number of subjects: 170
Study: 3099313

Group type: EXPERIMENTAL
Intervention: Enprostil (35 mcg) administered 25 min before a meal (anti-cibum AC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enprostil (35 mcg) administered 5 min after a meal (post-cibum PC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo administered 25 min before a meal (anti-cibum AC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo administered 5 min after a meal (post-cibum PC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enprostil (AC or PC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enprostil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enprostil (PC)
Number of subjects: 30
Study: 29752149

Group type: EXPERIMENTAL
Intervention: Limb occlusion pressure (LOP) determination
Number of subjects: 93

Group type: COMPARATOR
Intervention: Arterial occlusion pressure (AOP) estimation
Number of subjects: 93
Study: 26881981

Group type: EXPERIMENTAL
Intervention: Premium-feature hearing aids
Number of subjects: 45

Group type: COMPARATOR
Intervention: Basic-feature hearing aids
Number of subjects: 45
Study: 24433234

Group type: EXPERIMENTAL
Intervention: TIRSFSP guided by a stroke support person, delivered in-person during acute care and by telephone for approximately the first six to 12 months post-stroke
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Caregiver self-directed TIRSFSP with an initial introduction to the program by a stroke support person
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care receiving the educational resource 'Let's Talk about Stroke' prepared by the Heart and Stroke Foundation
Number of subjects: 300
Study: 22722516

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 19651631

Group type: EXPERIMENTAL
Intervention: High dose PPI therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low dose PPI therapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Prolonged PPI use
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gastrin (1 ng/ml) on OE33(E)(cckr) Barrett's oesophagus cells
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gastrin (100 ng/ml) on OE33(E)(cckr) Barrett's oesophagus cells
Number of subjects: 90
Study: 18922570

Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg)
Number of subjects: 2587

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2587
Study: 15673861

Group type: EXPERIMENTAL
Intervention: Nicardipine 40 mug/kg IV
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nicardipine 80 mug/kg IV
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 25
Study: 12085041

Group type: EXPERIMENTAL
Intervention: Sodium Phosphate (NaP)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Magnesium Citrate (Mg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sodium Phosphate (NaP) diluted into 3 doses 10 minutes apart
Number of subjects: 300
Study: 10435801

Group type: EXPERIMENTAL
Intervention: Hyperfractionation (HF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late normal tissue damage
Number of subjects: 0
Study: 7598849

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 69

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 69
Study: 2195862

Group type: EXPERIMENTAL
Intervention: Magnesium infusion for 48 hours
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo (isotonic glucose)
Number of subjects: 103
Study: 368231

Group type: EXPERIMENTAL
Intervention: Glucose electrolyte solution
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sucrose electrolyte solution
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 73
Study: 30221374

Group type: EXPERIMENTAL
Intervention: Unfamiliar listeners
Number of subjects: 3

Group type: COMPARATOR
Intervention: Familiar listeners
Number of subjects: 3
Study: 29750828

Group type: EXPERIMENTAL
Intervention: Romosozumab 210 mg once monthly for 12 months
Number of subjects: 7180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7180

Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 7180
Study: 26716862

Group type: EXPERIMENTAL
Intervention: 100% oxygen with positive-pressure ventilation (PSV) - positive inspiratory pressure of 4 cmH2O and positive end-expiratory pressure of 4 cmH2O
Number of subjects: 50

Group type: COMPARATOR
Intervention: 100% oxygen at neutral pressure (Control group)
Number of subjects: 50
Study: 23403530

Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention with self-determined goal
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention with specific goal of 2500 steps/day above baseline
Number of subjects: 41
Study: 22385937

Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stepped pharmacologic care
Number of subjects: 0
Study: 20516425

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/d
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 17706091

Group type: EXPERIMENTAL
Intervention: Viscocanalostomy (VCO)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 100
Study: 15616025

Group type: EXPERIMENTAL
Intervention: Family history of diabetes
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: Waist-to-height index
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: Beta-cell function adjusted for insulin resistance
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: Combination of FPG > or =5.6 mmol/l, BMI > or =30 kg/m(2), and family history of diabetes
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: FPG > or =6.1 mmol/l or 2-h glucose > or =7.8 mmol/l
Number of subjects: 2115
Study: 11994796

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block using near-nerve electromyographically guided technique
Number of subjects: 41

Group type: COMPARATOR
Intervention: Suprascapular nerve block using needle tip guided by superficial bony landmarks
Number of subjects: 41
Study: 9661563

Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 40
Study: 7661335

Group type: EXPERIMENTAL
Intervention: HHL (10% hydroxyethylstarch 200/0.5 in 7.2% saline)
Number of subjects: 21

Group type: COMPARATOR
Intervention: HA (5% albumin)
Number of subjects: 21

Group type: COMPARATOR
Intervention: HES (6% hydroxyethylstarch in 0.9% saline)
Number of subjects: 21
Study: 2698394

Group type: EXPERIMENTAL
Intervention: Lactate infusion in MVA patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: MVA patients
Number of subjects: 30
Study: 128498

Group type: EXPERIMENTAL
Intervention: Iotroxamid (Chologram)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ioglycamid (Bilivistan)
Number of subjects: 0
Study: 6784976

Group type: EXPERIMENTAL
Intervention: Bromocriptine 7.5 mg daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31711489

Group type: EXPERIMENTAL
Intervention: Uncomplicated malaria
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Severe malaria
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Uncomplicated malaria (children under five)
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Severe malaria (children under five)
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Uncomplicated malaria (health system costs)
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Severe malaria (health system costs)
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Overall cost of malaria care to society
Number of subjects: 1373
Study: 28298031

Group type: EXPERIMENTAL
Intervention: Clipping
Number of subjects: 362

Group type: COMPARATOR
Intervention: Coiling
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Both Clipping and Coiling
Number of subjects: 362
Study: 27018305

Group type: EXPERIMENTAL
Intervention: Assisted Cycling Therapy (ACT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Voluntary Cycling (VC)
Number of subjects: 44
Study: 25935960

Group type: EXPERIMENTAL
Intervention: Hysteroscopy-laparoscopy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Folic acid 5 mg/day (Control)
Number of subjects: 200
Study: 22420866

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 26
Study: 20813019

Group type: EXPERIMENTAL
Intervention: Task-oriented training with trunk restraint
Number of subjects: 12

Group type: COMPARATOR
Intervention: Task-oriented training without trunk restraint
Number of subjects: 12
Study: 17605536

Group type: EXPERIMENTAL
Intervention: Community‐university partnership model for recruitment
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Community team functioning and technical assistance variables
Number of subjects: 14
Study: 16046381

Group type: EXPERIMENTAL
Intervention: Thermal therapy (60 degrees C far-infrared ray dry sauna for 15 minutes, followed by bed rest with a blanket for 30 minutes, once a day, 5 days a week for 20 sessions in 4 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nonthermal therapy (control group)
Number of subjects: 28
Study: 12500883

Group type: EXPERIMENTAL
Intervention: Guideline summary, performance feedback, and medical chart reminders
Number of subjects: 1189

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1189
Study: 9860109

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg administered orally at 0700 and 1600 hours on days 3, 4, and 5)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 7895560

Group type: EXPERIMENTAL
Intervention: Ranitidine (6.25 mg/hr continuous infusion)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34